Mathilde Bayet-Robert

Summary

Country: France

Publications

  1. ncbi request reprint Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer
    Mathilde Bayet-Robert
    Centre Jean Perrin, Division de Recherche Clinique, Universite d Auvergne, centre d investigation clinique, Clermont Ferrand, France
    Cancer Biol Ther 9:8-14. 2010
  2. doi request reprint Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?
    Olivier Tacca
    Bureau de Recherche Clinique, Centre Jean Perrin, Clermont Ferrand Cedex 1, France
    Cancer Invest 27:81-5. 2009
  3. doi request reprint Biochemical disorders induced by cytotoxic marine natural products in breast cancer cells as revealed by proton NMR spectroscopy-based metabolomics
    Mathilde Bayet-Robert
    Universite d Auvergne, 28 Place Henri Dunant, 63001 Clermont Ferrand, France
    Biochem Pharmacol 80:1170-9. 2010
  4. doi request reprint Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment
    Aurélie Cabrespine-Faugeras
    Hotel Dieu Pavillon Villemin Pasteur, Clermont Ferrand, France
    Nutr Cancer 62:148-53. 2010
  5. doi request reprint Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses
    Mathilde Bayet-Robert
    Centre Jean Perrin, Universite d Auvergne, 58 rue Montalembert, 63011, Clermont Ferrand, France
    Breast Cancer Res Treat 120:613-26. 2010
  6. doi request reprint Quantitative two-dimensional HRMAS 1H-NMR spectroscopy-based metabolite profiling of human cancer cell lines and response to chemotherapy
    Mathilde Bayet-Robert
    Universite d Auvergne, Clermont Ferrand, France
    Magn Reson Med 63:1172-83. 2010

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer
    Mathilde Bayet-Robert
    Centre Jean Perrin, Division de Recherche Clinique, Universite d Auvergne, centre d investigation clinique, Clermont Ferrand, France
    Cancer Biol Ther 9:8-14. 2010
    ....
  2. doi request reprint Metastatic breast cancer: overall survival related to successive chemotherapies. What do we gain after the third line?
    Olivier Tacca
    Bureau de Recherche Clinique, Centre Jean Perrin, Clermont Ferrand Cedex 1, France
    Cancer Invest 27:81-5. 2009
    ..In our study, it appeared useful to give several CT lines when possible. Subsequent lines of CT could have a beneficial effect on the survival for some patients with MBC...
  3. doi request reprint Biochemical disorders induced by cytotoxic marine natural products in breast cancer cells as revealed by proton NMR spectroscopy-based metabolomics
    Mathilde Bayet-Robert
    Universite d Auvergne, 28 Place Henri Dunant, 63001 Clermont Ferrand, France
    Biochem Pharmacol 80:1170-9. 2010
    ..Altogether, this study demonstrates the potential of proton NMR spectroscopy-based metabolomics to help uncover metabolic targets and elucidate the mechanism of cytotoxicity of candidate antineoplastic MNPs...
  4. doi request reprint Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment
    Aurélie Cabrespine-Faugeras
    Hotel Dieu Pavillon Villemin Pasteur, Clermont Ferrand, France
    Nutr Cancer 62:148-53. 2010
    ..As a consequence, a rationale is provided for considering the possible benefits of curcumin regimen in combination with taxane therapy in HRPC patients...
  5. doi request reprint Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses
    Mathilde Bayet-Robert
    Centre Jean Perrin, Universite d Auvergne, 58 rue Montalembert, 63011, Clermont Ferrand, France
    Breast Cancer Res Treat 120:613-26. 2010
    ..01). Altogether, this pharmacometabolomics analysis provides further evidence of the varying cellular responses at high and low doses of docetaxel in MCF7 breast cancer cells...
  6. doi request reprint Quantitative two-dimensional HRMAS 1H-NMR spectroscopy-based metabolite profiling of human cancer cell lines and response to chemotherapy
    Mathilde Bayet-Robert
    Universite d Auvergne, Clermont Ferrand, France
    Magn Reson Med 63:1172-83. 2010
    ..The method may prove widely applicable to tumor cell phenotyping...